Stay updated on SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, signaling a minor page build update. No study content or user-facing details are affected by this change.
    Difference
    0.1%
    Check dated 2026-06-05T15:55:49.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, indicating an update to the study record. This change reflects version control activity rather than a substantive modification to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T05:50:45.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision/version label has been updated from v3.5.0 to v3.5.3, indicating a minor site release rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:42.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Napoli, Italy was updated to Naples, Italy in the locations list.
    Difference
    0.1%
    Check dated 2026-03-26T11:37:11.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:12:48.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces the previous v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T02:48:06.000Z thumbnail image

Stay in the know with updates to SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.